Glenmark Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE935A01035
  • NSEID: GLENMARK
  • BSEID: 532296
INR
2,168.50
72.8 (3.47%)
BSENSE

Mar 25

BSE+NSE Vol: 4.71 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 780863,
    "name": "Glenmark Pharma",
    "stock_name": "Glenmark Pharma",
    "full_name": "Glenmark Pharmaceuticals Ltd.",
    "name_url": "stocks-analysis/glenmark-pharma",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,168.50",
    "chg": 72.8,
    "chgp": "3.47%",
    "dir": 1,
    "prev_price": "2,095.70",
    "mcapval": "60,143.00 Cr",
    "mcap": "Mid Cap",
    "scripcode": 532296,
    "symbol": "GLENMARK",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE935A01035",
    "curr_date": "Mar 25",
    "curr_time": "",
    "bse_nse_vol": "4.71 lacs",
    "exc_status": "Active",
    "traded_date": "Mar 25, 2026",
    "traded_date_str": "2026 03 25",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/glenmark-pharma-780863-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "text": "Part of MojoOne Strategy",
      "type": "SM",
      "url": "https://www.marketsmojo.com/mojopro/stock-of-the-month",
      "ismore": 0,
      "all_data": [],
      "is_blur": 1,
      "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/glenmark-pharma-780863-1&utm_source=Spage_Score_PartofStrategies"
    }
  },
  "news": {
    "results": [
      {
        "title": "Glenmark Pharmaceuticals Sees Sharp Open Interest Surge Amid Bullish Market Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/glenmark-pharmaceuticals-sees-sharp-open-interest-surge-amid-bullish-market-momentum-3916513",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GlenmarkPharmac_oi_spurts_by_underlying_3916513.png",
        "date": "2026-03-25 15:00:49",
        "description": "Glenmark Pharmaceuticals Ltd. has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and potential directional bets. The stock outperformed its sector peers, supported by robust volume and positive price action, reflecting renewed investor confidence in the mid-cap pharmaceutical player."
      },
      {
        "title": "Glenmark Pharmaceuticals Sees Sharp Open Interest Surge Amid Bullish Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/glenmark-pharmaceuticals-sees-sharp-open-interest-surge-amid-bullish-momentum-3916376",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GlenmarkPharmac_oi_spurts_by_underlying_3916376.png",
        "date": "2026-03-25 14:00:38",
        "description": "Glenmark Pharmaceuticals Ltd. has witnessed a significant surge in open interest (OI) in its derivatives segment, signalling heightened market activity and shifting investor positioning. The stock’s recent outperformance relative to its sector and the broader market, combined with rising volumes and a notable increase in futures and options value, suggests growing bullish sentiment among traders."
      },
      {
        "title": "Glenmark Pharmaceuticals Sees Sharp Open Interest Surge Amid Mixed Price Action",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/glenmark-pharmaceuticals-sees-sharp-open-interest-surge-amid-mixed-price-action-3910785",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GlenmarkPharmac_oi_spurts_by_underlying_3910785.png",
        "date": "2026-03-24 15:00:36",
        "description": "Glenmark Pharmaceuticals Ltd. has witnessed a significant 18.9% surge in open interest in its derivatives segment, signalling heightened market activity despite recent price underperformance. This spike in open interest, coupled with volume patterns and shifting investor positioning, suggests evolving directional bets on the mid-cap pharmaceutical player amid a cautious sector backdrop."
      },
      {
        "title": "Glenmark Pharmaceuticals Sees Sharp Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/glenmark-pharmaceuticals-sees-sharp-open-interest-surge-amid-mixed-market-signals-3910658",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GlenmarkPharmac_oi_spurts_by_underlying_3910658.png",
        "date": "2026-03-24 14:00:31",
        "description": "Glenmark Pharmaceuticals Ltd. has witnessed a significant 23.15% surge in open interest in its derivatives segment, signalling heightened market activity and shifting positioning among traders. Despite this, the stock underperformed its sector and broader indices, reflecting a complex interplay of investor sentiment and technical factors."
      },
      {
        "title": "Glenmark Pharmaceuticals Sees Sharp Surge in Open Interest Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/glenmark-pharmaceuticals-sees-sharp-surge-in-open-interest-amid-mixed-market-signals-3910533",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GlenmarkPharmac_oi_spurts_by_underlying_3910533.png",
        "date": "2026-03-24 13:00:25",
        "description": "Glenmark Pharmaceuticals Ltd. has witnessed a significant 21.25% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a modest 0.83% gain in the stock price, the underlying dynamics suggest a complex interplay of directional bets and liquidity flows within the mid-cap pharmaceutical sector."
      },
      {
        "title": "Glenmark Pharmaceuticals Sees Sharp Open Interest Surge Amid Mixed Price Action",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/glenmark-pharmaceuticals-sees-sharp-open-interest-surge-amid-mixed-price-action-3910397",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GlenmarkPharmac_oi_spurts_by_underlying_3910397.png",
        "date": "2026-03-24 12:00:12",
        "description": "Glenmark Pharmaceuticals Ltd. has witnessed a notable 19.9% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this, the stock marginally underperformed its sector and broader indices, reflecting a complex interplay between bullish bets and cautious sentiment among traders."
      },
      {
        "title": "Why is Glenmark Pharmaceuticals Ltd. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-glenmark-pharmaceuticals-ltd-fallingrising-3897834",
        "imagepath": "",
        "date": "2026-03-18 01:20:34",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Short-Term Price Movement and Market Context</strong></p>\n<p>Despite the recent fall, Glenmark’s stock has demonstrated resilience over longer periods. The one-week return shows a decline of 4.05%, which is steeper than the Sensex’s 2.73% drop, indicating some short-term underperformance relative to the broader market. However, over the past month, the stock has gained 4.89%, contrasting with the Sensex’s 8.84% loss, and year-to-date it has risen by 5.01% while the benchmark index has declined by 10.74%. These figures suggest that while the stock faced pressure on 17-Mar, it remains a strong performer in a challenging market environment.</p>\n<p>On the day in question, Glenmark underperformed its sector by 2.01%, and the share price was trading below its five-day moving average, though it rem..."
      },
      {
        "title": "Glenmark Pharmaceuticals Ltd. is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/glenmark-pharmaceuticals-ltd-is-rated-buy-3896250",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GlenmarkPharmac_mojoScore_3896250.png",
        "date": "2026-03-17 10:10:32",
        "description": "Glenmark Pharmaceuticals Ltd. is rated Buy by MarketsMOJO, with this rating last updated on 31 January 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock’s current position as of 17 March 2026, providing investors with the most up-to-date insight into the company’s performance and outlook."
      },
      {
        "title": "Glenmark Pharmaceuticals Gains 2.25%: 3 Key Factors Driving the Week’s Resilience",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/glenmark-pharmaceuticals-gains-225-3-key-factors-driving-the-weeks-resilience-3891102",
        "imagepath": "",
        "date": "2026-03-14 13:04:20",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Mar 09:</strong> Stock opens at Rs.2,116.85 amid Sensex decline</p>\n                    <p><strong>Mar 10:</strong> Intraday high surge of 5.08% and surge in call option activity</p>\n                    <p><strong>Mar 11:</strong> New 52-week high at Rs.2,297.20</p>\n                    <p><strong>Mar 13:</strong> Week closes at Rs.2,170.00, down 3.90% on the day</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.2,122.15</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.2,170.00</div><d..."
      }
    ],
    "total": 506,
    "sid": "780863",
    "stock_news_url": "https://www.marketsmojo.com/news/glenmark-pharmaceuticals-780863"
  },
  "announcements": [
    {
      "details": "Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 26, 2019, titled \"Glenmark Pharmaceuticals receives ANDA approval for Metformin Hydrochloride Extended-Release Tablets USP,",
      "source": "NSE",
      "caption": "Glenmark Pharmaceuticals Limited - Press Release",
      "datetime": "26-Nov-2019"
    },
    {
      "details": "Glenmark Pharmaceuticals Limited has informed the Exchange regarding Grant of 20000 Options.",
      "source": "NSE",
      "caption": "Glenmark Pharmaceuticals Limited - ESOP/ESOS/ESPS",
      "datetime": "15-Nov-2019"
    },
    {
      "details": "Glenmark Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015",
      "source": "NSE",
      "caption": "Glenmark Pharmaceuticals Limited - Trading Window",
      "datetime": "06-Nov-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Glenmark Pharmaceuticals Ltd. has declared <strong>250%</strong> dividend, ex-date: 03 Oct 25",
          "dt": "2025-10-03",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Glenmark Pharmaceuticals Ltd. has announced <strong>1:2</strong> stock split, ex-date: 10 Sep 07",
          "dt": "2007-09-10",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Why is Glenmark Pharmaceuticals Ltd. falling/rising?

2026-03-18 01:20:34

Short-Term Price Movement and Market Context

Despite the recent fall, Glenmark’s stock has demonstrated resilience over longer periods. The one-week return shows a decline of 4.05%, which is steeper than the Sensex’s 2.73% drop, indicating some short-term underperformance relative to the broader market. However, over the past month, the stock has gained 4.89%, contrasting with the Sensex’s 8.84% loss, and year-to-date it has risen by 5.01% while the benchmark index has declined by 10.74%. These figures suggest that while the stock faced pressure on 17-Mar, it remains a strong performer in a challenging market environment.

On the day in question, Glenmark underperformed its sector by 2.01%, and the share price was trading below its five-day moving average, though it rem...

Read full news article
stock-recommendationAnnouncement

Glenmark Pharmaceuticals Limited - Press Release

26-Nov-2019 | Source : NSE

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 26, 2019, titled "Glenmark Pharmaceuticals receives ANDA approval for Metformin Hydrochloride Extended-Release Tablets USP,

Glenmark Pharmaceuticals Limited - ESOP/ESOS/ESPS

15-Nov-2019 | Source : NSE

Glenmark Pharmaceuticals Limited has informed the Exchange regarding Grant of 20000 Options.

Glenmark Pharmaceuticals Limited - Trading Window

06-Nov-2019 | Source : NSE

Glenmark Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Glenmark Pharmaceuticals Ltd. has declared 250% dividend, ex-date: 03 Oct 25

stock-summary
SPLITS

Glenmark Pharmaceuticals Ltd. has announced 1:2 stock split, ex-date: 10 Sep 07

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available